Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective α1a-adrenergic receptor antagonists

被引:52
作者
Lagu, B
Tian, D
Chiu, G
Nagarathnam, D
Fang, J
Shen, QR
Forray, C
Ransom, RW
Chang, RSL
Vyas, KP
Zhang, KY
Gluchowski, C
机构
[1] Synapt Pharmaceut Corp, Dept Chem, Paramus, NJ 07652 USA
[2] Synapt Pharmaceut Corp, Dept Pharmacol, Paramus, NJ 07652 USA
[3] Merck Sharp & Dohme Ltd, Dept Pharmacol, W Point, PA 19486 USA
[4] Merck Sharp & Dohme Ltd, Dept Drug Metab, W Point, PA 19486 USA
关键词
D O I
10.1016/S0960-894X(99)00653-8
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Furo[3,4-d]pyrimidinones were found to be metabolites of dihydropyrimidinones such as 1a-b that are subtype-selective antagonists of the alpha(1a)-adrenergic receptor. A versatile synthesis that provides access to furo[3,4-d]pyrimidinones in high yield and in enantiomerically pure forms is described along with structure-activity relationships in the series. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:175 / 178
页数:4
相关论文
共 11 条
[1]   DIHYDROPYRIMIDINE CALCIUM-CHANNEL BLOCKERS - 2-HETEROSUBSTITUTED 4-ARYL-1,4-DIHYDRO-6-METHYL-5-PYRIMIDINECARBOXYLIC ACID-ESTERS AS POTENT MIMICS OF DIHYDROPYRIDINES [J].
ATWAL, KS ;
ROVNYAK, GC ;
SCHWARTZ, J ;
MORELAND, S ;
HEDBERG, A ;
GOUGOUTAS, JZ ;
MALLEY, MF ;
FLOYD, DM .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (05) :1510-1515
[2]   SYNTHESIS OF FURO[3,4-D]PYRIMIDINE DERIVATIVES USING ETHYL 4-BROMOACETOACETATE [J].
CHIBA, T ;
SATO, H ;
KATO, T .
HETEROCYCLES, 1984, 22 (03) :493-496
[3]   Design and synthesis of novel α1a adrenoceptor-selective antagonists.: 2.: Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety [J].
Dhar, TGM ;
Nagarathnam, D ;
Marzabadi, MR ;
Lagu, B ;
Wong, WC ;
Chiu, G ;
Tyagarajan, S ;
Miao, SW ;
Zhang, FQ ;
Sun, WY ;
Tian, D ;
Shen, QR ;
Zhang, J ;
Wetzel, JM ;
Forray, C ;
Chang, RSL ;
Broten, TP ;
Schorn, TW ;
Chen, TB ;
O'Malley, S ;
Ransom, R ;
Schneck, K ;
Bendesky, R ;
Harrell, CM ;
Vyas, KP ;
Zhang, KY ;
Gilbert, J ;
Pettibone, DJ ;
Patane, MA ;
Bock, MG ;
Freidinger, RM ;
Gluchowski, C .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (23) :4778-4793
[4]   Pharmacological options in the treatment of benign prostatic hyperplasia [J].
Kenny, B ;
Ballard, S ;
Blagg, J ;
Fox, D .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (09) :1293-1315
[5]  
KIRBY RS, 1993, BENIGN PROSTATIC HYP, P1
[6]  
KNEPPER SM, 1995, J PHARMACOL EXP THER, V274, P97
[7]   Design and synthesis of novel α1a adrenoceptor-selective antagonists.: 3.: Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains [J].
Lagu, B ;
Tian, D ;
Nagarathnam, D ;
Marzabadi, MR ;
Wong, WC ;
Miao, SW ;
Zhang, FQ ;
Sun, WY ;
Chiu, G ;
Fang, J ;
Forray, C ;
Chang, RSL ;
Ransom, RW ;
Chen, TB ;
O'Malley, S ;
Zhang, KY ;
Vyas, KP ;
Gluchowski, C .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (23) :4794-4803
[8]   Design and synthesis of novel α1a adrenoceptor-selective antagonists.: 1.: Structure-activity relationship in dihydropyrimidinones [J].
Nagarathnam, D ;
Miao, SW ;
Lagu, B ;
Chiu, G ;
Fang, J ;
Dhar, TGM ;
Zhang, J ;
Tyagarajan, S ;
Marzabadi, MR ;
Zhang, FQ ;
Wong, WC ;
Sun, WY ;
Tian, D ;
Wetzel, JM ;
Forray, C ;
Chang, RSL ;
Broten, TP ;
Ransom, RW ;
Schorn, TW ;
Chen, TB ;
O'Malley, S ;
Kling, P ;
Schneck, K ;
Bendesky, R ;
Harrell, CM ;
Vyas, KP ;
Gluchowski, C .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (23) :4764-4777
[9]   CALCIUM-ENTRY BLOCKERS AND ACTIVATORS - CONFORMATIONAL AND STRUCTURAL DETERMINANTS OF DIHYDROPYRIMIDINE CALCIUM-CHANNEL MODULATORS [J].
ROVNYAK, GC ;
KIMBALL, SD ;
BEYER, B ;
CUCINOTTA, G ;
DIMARCO, JD ;
GOUGOUTAS, J ;
HEDBERG, A ;
MALLEY, M ;
MCCARTHY, JP ;
ZHANG, RA ;
MORELAND, S .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (01) :119-129
[10]   SUBSTITUTED GAMMA-LACTONES .32. CONDENSATION OF 2,4(3H,5H)-FURANDIONE WITH HETEROAROMATIC ALDEHYDES [J].
SCHMIDT, DG ;
ZIMMER, H .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1983, 20 (03) :787-789